Lv0
0 积分 2024-09-03 加入
A phase II study of anti–PD-1 antibody camrelizumab plus FOLFOX4 or GEMOX systemic chemotherapy as first-line therapy for advanced hepatocellular carcinoma or biliary tract cancer
3天前
求助中
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trial
3天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
30天前
已完结
Cancer incidence and mortality in China, 2022
30天前
已完结
Advances in Endoscopic Diagnosis and Treatment of Hilar Cholangiocarcinoma
30天前
已完结
Global epidemiology of kidney cancer
3个月前
已完结
Biliary tract cancer
3个月前
已完结
Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials
9个月前
已完结
Infusion-related reactions with immune checkpoint inhibitors in genitourinary cancers: A systematic review and meta-analysis
9个月前
已关闭
Cancer incidence and mortality in China, 2022
9个月前
已完结
皖公网安备34019202002308
